Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Urology|June 13, 2006
High-level virtual reality simulator for endourologic procedures of lower urinary tractOliver Reich, Margarita Noll, Christian Gratzke, et al.
European Urology|March 19, 2005
Retroperitoneoscopy-assisted cryoablation of renal tumors using multiple 1.5 mm ultrathin cryoprobes: a preliminary reportAlexander Bachmann, Tullio Sulser, Christian Jayet, et al.
BJU International|July 15, 2009
The role of lymphangiogenesis in lymphatic tumour spread of urological cancersChristian Bolenz, Mario I Fernández, Derya Tilki, et al.
Urologia Internationalis|February 5, 2011
Coupling of α1-adrenoceptors to ERK1/2 in the human prostateRicarda M Bauer, Frank Strittmatter, Christian Gratzke, et al.
Risk Management and Healthcare Policy|May 12, 2015
Anti-VEGF treatment patterns and associated health care costs in Switzerland: findings using real-world claims dataOliver Reich, Lucas M Bachmann, Livia Faes, et al.
Plos One|August 5, 2015
Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-LifeMartin K Schmid, Oliver Reich, Livia Faes, et al.
International Urology and Nephrology|May 16, 2012
The impact of bladder neck mucosal eversion during open radical prostatectomy on bladder neck stricture and urinary extravasationGita M Schoeppler, Dirk Zaak, Dirk-Andre Clevert, et al.
European Urology|June 21, 2011
Urine markers for detection and surveillance of non-muscle-invasive bladder cancerDerya Tilki, Maximilian Burger, Guido Dalbagni, et al.
European Urology|August 21, 2012
18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extentDerya Tilki, Oliver Reich, Anno Graser, et al.
BMC Ophthalmology|March 1, 2018
Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research contextMartin K Schmid, Oliver Reich, Eva Blozik, et al.
Pageof 15